Botulinum toxin type a injections for the management of muscle tightness following total hip arthroplasty: A case series

被引:13
作者
Bhave A. [1 ]
Zywiel M.G. [2 ]
Ulrich S.D. [2 ]
McGrath M.S. [2 ]
Seyler T.M. [3 ]
Marker D.R. [2 ]
Delanois R.E. [2 ]
Mont M.A. [2 ]
机构
[1] Rehabilitation Services, Rubin Institute for Advanced Orthopedics, Sinai Hospital of Baltimore, Baltimore, MD
[2] Center for Joint Preservation and Replacement, Rubin Institute for Advanced Orthopedics, Sinai Hospital of Baltimore, Baltimore, MD
[3] Department of Orthopaedic Surgery, Wake Forest University, School of Medicine, Winston-Salem, NC
关键词
Botulinum Toxin; Flexion Contracture; Muscle Contracture; Botulinum Toxin Injection; Botulinum Toxin Type;
D O I
10.1186/1749-799X-4-34
中图分类号
学科分类号
摘要
Background. Development of hip adductor, tensor fascia lata, and rectus femoris muscle contractures following total hip arthroplasties are quite common, with some patients failing to improve despite treatment with a variety of non-operative modalities. The purpose of the present study was to describe the use of and patient outcomes of botulinum toxin injections as an adjunctive treatment for muscle tightness following total hip arthroplasty. Methods. Ten patients (14 hips) who had hip adductor, abductor, and/or flexor muscle contractures following total arthroplasty and had been refractory to physical therapeutic efforts were treated with injection of botulinum toxin A. Eight limbs received injections into the adductor muscle, 8 limbs received injections into the tensor fascia lata muscle, and 2 limbs received injection into the rectus femoris muscle, followed by intensive physical therapy for 6 weeks. Results. At a mean final follow-up of 20 months, all 14 hips had increased range in the affected arc of motion, with a mean improvement of 23 degrees (range, 10 to 45 degrees). Additionally all hips had an improvement in hip scores, with a significant increase in mean score from 74 points (range, 57 to 91 points) prior to injection to a mean of 96 points (range, 93 to 98) at final follow-up. There were no serious treatment-related adverse events. Conclusion. Botulinum toxin A injections combined with intensive physical therapy may be considered as a potential treatment modality, especially in difficult cases of muscle tightness that are refractory to standard therapy.
引用
收藏
相关论文
共 28 条
[1]  
Weber M., Cabanela M.E., Sim F.H., Frassica F.J., Harmsen W.S., Total hip replacement in patients with Parkinson's disease, Int Orthop, 26, pp. 66-68, (2002)
[2]  
Bhave A., Marker D.R., Seyler T.M., Ulrich S.D., Plate J.F., Mont M.A., Functional Problems and Treatment Solutions After Total Hip Arthroplasty, Journal of Arthroplasty, 22, 6 SUPPL., pp. 116-124, (2007)
[3]  
Dohnke B., Knauper B., Muller-Fahrnow W., Perceived self-efficacy gained from, and health effects of, a rehabilitation program after hip joint replacement, Arthritis Rheum, 53, pp. 585-592, (2005)
[4]  
Youm T., Maurer S.G., Stuchin S.A., Postoperative management after total hip and knee arthroplasty, J Arthroplasty, 20, pp. 322-324, (2005)
[5]  
Alberton G.M., High W.A., Morrey B.F., Dislocation after revision total hip arthroplasty: An analysis of risk factors and treatment options, J Bone Joint Surg Am, 84, pp. 1788-1792, (2002)
[6]  
Bhave A., Mont M., Tennis S., Nickey M., Starr R., Etienne G., Functional problems and treatment solutions after total hip and knee joint arthroplasty, J Bone Joint Surg Am, 87, SUPPL 2, pp. 9-21, (2005)
[7]  
Ulrich S.D., Bhave A., Marker D.R., Seyler T.M., Mont M.A., Focused rehabilitation treatment of poorly functioning total knee arthroplasties, Clin Orthop Relat Res, 464, pp. 138-145, (2007)
[8]  
Alvarez C.M., Tredwell S.J., Keenan S.P., Beauchamp R.D., Choit R.L., Sawatzky B.J., De Vera M.A., Treatment of idiopathic clubfoot utilizing botulinum A toxin: A new method and its short-term outcomes, J Pediatr Orthop, 25, pp. 229-235, (2005)
[9]  
Koman L.A., Mooney III J.F., Smith B.P., Walker F., Leon J.M., Botulinum toxin type A neuromuscular blockade in the treatment of lower extremity spasticity in cerebral palsy: A randomized, double-blind, placebo-controlled trial. BOTOX Study Group, J Pediatr Orthop, 20, pp. 108-115, (2000)
[10]  
Sarioglu B., Serdaroglu G., Tutuncuoglu S., Ozer E.A., The use of botulinum toxin type A treatment in children with spasticity, Pediatr Neurol, 29, pp. 299-301, (2003)